| scholarly article | Q13442814 |
| P2093 | author name string | Peter C Gray | |
| Senyon Choe | |||
| Witek Kwiatkowski | |||
| Byung-Hak Yoon | |||
| Chihoon Ahn | |||
| Luis Esquivies | |||
| Sang-Kyu Ye | |||
| P2860 | cites work | Bone morphogenetic protein (BMP) for fracture healing in adults | Q24234838 |
| Structural basis for the inhibition of activin signalling by follistatin. | Q24304947 | ||
| MADR1, a MAD-related protein that functions in BMP2 signaling pathways | Q24317247 | ||
| MOLSCRIPT: a program to produce both detailed and schematic plots of protein structures | Q26778412 | ||
| TGF-β and BMP signaling in osteoblast differentiation and bone formation | Q26995720 | ||
| Crystal structure of human bone morphogenetic protein-2 at 2.7 A resolution | Q27617482 | ||
| Structures of an ActRIIB:activin A complex reveal a novel binding mode for TGF-beta ligand:receptor interactions | Q27640830 | ||
| The BMP7/ActRII extracellular domain complex provides new insights into the cooperative nature of receptor assembly | Q27640861 | ||
| BMP-3 and BMP-6 structures illuminate the nature of binding specificity with receptors | Q27648733 | ||
| XDS | Q27860472 | ||
| REFMAC5 for the refinement of macromolecular crystal structures | Q27860905 | ||
| Features and development of Coot | Q27861079 | ||
| Identification of a binding site on the type II activin receptor for activin and inhibin | Q28143632 | ||
| Smad signalling network | Q28216727 | ||
| Crystal structure of BMP-9 and functional interactions with pro-region and receptors | Q28246829 | ||
| Bone: formation by autoinduction | Q28251545 | ||
| The use of recombinant human bone morphogenetic protein-2 (rhBMP-2) in orthopaedic applications | Q28262713 | ||
| Specific activation of Smad1 signaling pathways by the BMP7 type I receptor, ALK2 | Q28283345 | ||
| Designer TGFβ superfamily ligands with diversified functionality | Q28477811 | ||
| A flexible activin explains the membrane-dependent cooperative assembly of TGF-beta family receptors | Q28506741 | ||
| Smad8 mediates the signaling of the ALK-2 [corrected] receptor serine kinase | Q28584256 | ||
| Mesenchymal stem cells expressing osteogenic and angiogenic factors synergistically enhance bone formation in a mouse model of segmental bone defect. | Q33931650 | ||
| Serine/threonine kinase receptors: mediators of transforming growth factor beta family signals. | Q34406617 | ||
| Structure of the ternary signaling complex of a TGF-beta superfamily member | Q34589783 | ||
| Studies of bone morphogenetic protein-based surgical repair | Q36106613 | ||
| Characterization and cloning of a receptor for BMP-2 and BMP-4 from NIH 3T3 cells. | Q36665327 | ||
| Serine/threonine kinase receptors | Q36751950 | ||
| Smad5 and DPC4 are key molecules in mediating BMP-2-induced osteoblastic differentiation of the pluripotent mesenchymal precursor cell line C2C12. | Q41069920 | ||
| Activin receptors: cellular signalling by receptor serine kinases | Q41275966 | ||
| High doses of bone morphogenetic protein 2 induce structurally abnormal bone and inflammation in vivo | Q42094508 | ||
| From mono- to oligo-Smads: the heart of the matter in TGF-beta signal transduction | Q44087089 | ||
| A standardized experimental fracture in the mouse tibia | Q70682553 | ||
| Identification of type I receptors for osteogenic protein-1 and bone morphogenetic protein-4 | Q72000906 | ||
| Interbody fusion with allograft and rhBMP-2 leads to consistent fusion but early subsidence | Q79931833 | ||
| P4510 | describes a project that uses | ImageJ | Q1659584 |
| P433 | issue | 9 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 1950-9 | |
| P577 | publication date | 2014-09-01 | |
| P1433 | published in | Journal of Bone and Mineral Research | Q15750941 |
| P1476 | title | An Activin A/BMP2 Chimera, AB204, Displays Bone-Healing Properties Superior to Those of BMP2 | |
| P478 | volume | 29 |
| Q26739015 | A Survey of Strategies to Modulate the Bone Morphogenetic Protein Signaling Pathway: Current and Future Perspectives |
| Q58560531 | Activin A/BMP2 Chimera (AB204) Exhibits Better Spinal Bone Fusion Properties than rhBMP2 |
| Q38733364 | Bone Morphogenetic Protein-Based Therapeutic Approaches |
| Q38400680 | Genetic Approaches To Identifying Novel Osteoporosis Drug Targets |
| Q31052456 | Investigational drugs for fracture healing: preclinical & clinical data. |
| Q64104312 | Investigational growth factors utilized in animal models of spinal fusion: Systematic review |
| Q38957057 | Structural Biology and Evolution of the TGF-β Family |
| Q91967330 | Structural characterization of an activin class ternary receptor complex reveals a third paradigm for receptor specificity |
| Q46017727 | The Cardiovascular Effect of Single Injection and Toxicologic Effects of Repetitive 2-Week Intravenous Administration of Activin A/BMP-2 Chimera in Beagle Dog. |
| Q46142386 | The activin-βA/BMP-2 chimera AB204 is a strong stimulator of adipogenesis |
| Q46248136 | The effects of a single intravenous injection of novel activin A/BMP-2 (AB204) on toxicity and the respiratory and central nervous systems |
| Q85455506 | The toxicological evaluation of repetitive 2- and 4-week intravenous injection of Activin A/BMP-2 chimera (AB204) into rats |
Search more.